HIV inhibiting 5-substituted pyrimidines

Details for Australian Patent Application No. 2005288866 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Guillemont, Jerome Emile Georges; Heeres, Jan; Lewi, Paulus Joannes

Agent Shelston IP

Pub. Number AU-B-2005288866

PCT Pub. Number WO2006/035069

Priority 04104805.9 30.09.04 EP

Filing date 29 September 2005

Wipo publication date 6 April 2006

Acceptance publication date 26 July 2012

International Classifications

C07D 239/48 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 - Pyrimidines

A61P 31/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 239/50 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/035069 Priority application(s): WO2006/035069

26 July 2012 Application Accepted

  Published as AU-B-2005288866

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005288887-Separation method using an ITQ-29 zeolite material

2005288865-HIV inhibiting 5-carboor heterocyclic substituted pyrimidines